According to a recent LinkedIn post from Artera, United Health Services is depicted as using the company’s automated text outreach to address care gaps for diabetes patients. The post highlights that replacing manual phone calls with Artera’s platform is associated with an 11.4% improvement in A1c control over a 24‑month period.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post points readers to a blog featuring commentary from a senior director at UHS focused on care coordination and health equity. For investors, this suggested outcome-based metric and reference customer may indicate rising adoption of Artera’s patient engagement tools in chronic disease management, a segment where demonstrable clinical improvements can support pricing power and longer‑term revenue resilience.
The emphasis on automating outreach and replacing manual workflows also implies potential efficiency gains for provider organizations, which could strengthen Artera’s value proposition in an environment of labor constraints. If similar results are replicated at scale, Artera could deepen penetration in health systems and expand use cases beyond diabetes, potentially broadening its addressable market within digital health and care coordination solutions.

